IMDX
Insight Molecular Diagnostics Inc. Common Stock
IMDX
IMDX
24 hedge funds and large institutions have $11.5M invested in Insight Molecular Diagnostics Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 6 closing their positions.
Holders
24
Holders Change
-3
Holders Change %
-11.11%
% of All Funds
0.54%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
2
Reduced
6
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Commonwealth Equity Services
Waltham,
Massachusetts
|
$40K |
2 |
TRCT
2
Tower Research Capital (TRC)
New York
|
$3K |
3 |
3
UBS Group
Zurich,
Switzerland
|
$2K |
4 |
4
Morgan Stanley
New York
|
$41K |